4//SEC Filing
Baltrus Victoria 4
Accession 0001562180-24-006659
CIK 0001568651other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 8:36 PM ET
Size
28.8 KB
Accession
0001562180-24-006659
Insider Transaction Report
Form 4
Baltrus Victoria
Chief Accounting Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-09-01+4,811→ 132,366 total - Exercise/Conversion
Class A Common Stock
2024-09-01+4,120→ 136,486 total - Exercise/Conversion
Class A Common Stock
2024-09-01+7,500→ 143,986 total - Sale
Class A Common Stock
2024-09-03$17.99/sh−4,226$76,026→ 140,648 total - Exercise/Conversion
Restricted Stock Units
2024-09-01−4,120→ 8,241 total→ Class A Common Stock (4,120 underlying) - Exercise/Conversion
Restricted Stock Units
2024-09-01−7,500→ 44,998 total→ Class A Common Stock (7,500 underlying) - Exercise/Conversion
Class A Common Stock
2024-09-01+888→ 144,874 total - Sale
Class A Common Stock
2024-09-04$17.46/sh−2,121$37,033→ 138,527 total - Sale
Class A Common Stock
2024-09-04$17.85/sh−1,731$30,898→ 136,796 total - Exercise/Conversion
Restricted Stock Units
2024-09-01−4,811→ 19,243 total→ Class A Common Stock (4,811 underlying) - Exercise/Conversion
Restricted Stock Units
2024-09-01−888→ 8,877 total→ Class A Common Stock (888 underlying)
Footnotes (9)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F6]The restricted stock units vested with respect to 25% of the shares on September 1, 2022, and will vest with respect to the remaining shares in 12 equal quarterly installments thereafter.
- [F7]The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2022.
- [F8]The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2023.
- [F9]The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2024.
Issuer
Oscar Health, Inc.
CIK 0001568651
Entity typeother
Related Parties
1- filerCIK 0001911946
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 8:36 PM ET
- Size
- 28.8 KB